Magenta Therapeutics Inc
Change company Symbol lookup
Select an option...
MGTA Magenta Therapeutics Inc
FLR Fluor Corp
DMPI DelMar Pharmaceuticals Inc
SPLK Splunk Inc
LB L Brands Inc
TEAM Atlassian Corporation PLC
GRAS Greenfield Farms Food Inc
CMS CMS Energy Corp
BAC Bank of America Corp
HPQ HP Inc
Go

Health Care : Biotechnology | Company profile

Magenta Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is developing therapeutics to transform hematopoietic stem cell transplants for patients with immune and blood-based diseases. It maintains a platform with integrated and modular approach, which aims to reboot the blood and immune systems. The Company’s products include MGTA-145, MGTA-456, E478, and G100. The Company also developing a pipeline of small molecules; biologics, including antibody drug conjugates; and a cell therapy, which transplant options for many more patients with autoimmune diseases, blood cancers and genetic diseases. The Company’s C100 program targets HSCs, immune cells, and disease-causing cells, the C200 program targets HSCs and disease-causing cells and the C300 program targets only immune cells. This is achieved by tuning the antibodies to specific cellular markers or receptors that are expressed on the particular cell types.

Price
Delayed
$17.10
Day's Change
-0.03 (-0.18%)
Bid
--
Ask
--
B/A Size
--
Day's High
16.95
Day's Low
16.85
Volume
(Light)

Today's volume of 46,662 shares is on pace to be much lighter than MGTA's 10-day average volume of 191,195 shares.

46,662
  • Prev Close
    17.13
  • Today's Open
    16.95
  • Day's Range
    16.85-16.95
  • Avg Vol (10-day)
    191.2K
  • Last (time)
    12:22p ET 05/23/19
  • Last (size)
    100
  • 52-Wk Range
    5.31 - 21.00
    LowHigh
  • (12/28/18 - 03/26/19)
    18.57%
  • 77.8%
  • Market Cap
    575.5M
  • Shares Outstanding
    33.7M
  • -4.56
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • --
  • 78.06
  • (% of float 04/30/19)
    5.66

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.